1. Home
  2. FMBH vs AVLN Comparison

FMBH vs AVLN Comparison

Compare FMBH & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Mid Bancshares Inc.

FMBH

First Mid Bancshares Inc.

N/A

Current Price

$50.68

Market Cap

1.3B

Sector

Finance

ML Signal

N/A

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$35.33

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FMBH
AVLN
Founded
1865
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
FMBH
AVLN
Price
$50.68
$35.33
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$43.40
N/A
AVG Volume (30 Days)
93.3K
168.0K
Earning Date
04-29-2026
N/A
Dividend Yield
2.33%
N/A
EPS Growth
16.06
N/A
EPS
2.10
N/A
Revenue
N/A
N/A
Revenue This Year
$9.30
N/A
Revenue Next Year
$6.66
N/A
P/E Ratio
$24.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.51
$24.90
52 Week High
$53.36
$40.17

Technical Indicators

Market Signals
Indicator
FMBH
AVLN
Relative Strength Index (RSI) 57.39 55.36
Support Level $50.49 $34.22
Resistance Level $53.36 $40.08
Average True Range (ATR) 0.91 1.91
MACD -0.10 -0.46
Stochastic Oscillator 74.84 35.63

Price Performance

Historical Comparison
FMBH
AVLN

About FMBH First Mid Bancshares Inc.

First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: